Mirae Asset Global ETFs Holdings’s SELLAS Life Sciences SLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.71M Buy
114,775
+16,486
+17% +$114K ﹤0.01% 1336
2026
Q1
$412K Buy
98,289
+40,742
+71% +$182K ﹤0.01% 1982
2025
Q4
$217K Buy
57,547
+12,900
+29% +$25.1K ﹤0.01% 2318
2025
Q3
$71.9K Sell
44,647
-7,563
-14% -$13.5K ﹤0.01% 2815
2025
Q2
$114K Buy
+52,210
New +$80.1K ﹤0.01% 2541

Other funds holding SLS

Mirae Asset Global ETFs Holdings's SLS Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its SELLAS Life Sciences (SLS) stake by 17% in Q2 2026, buying an estimated $114K and bringing the position to 114,775 shares worth $1.71M. The position accounts for ﹤0.01% of the portfolio, ranked #1336.

Mirae Asset Global ETFs Holdings first reported a position in SLS in Q2 2025 and has held it in 5 quarters since. 193 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 114,775 shares of SELLAS Life Sciences worth $1.71M as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 16,486 SELLAS Life Sciences shares in Q2 2026, an estimated $114K.
  • SELLAS Life Sciences made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1336 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in SELLAS Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • 193 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.